283 related articles for article (PubMed ID: 12738392)
41. Study of serum bactericidal and splenic activity of Total-OMP- CagA combination from Brucella abortus and Helicobacter pylori in BALB/c mouse model.
Abadi AH; Mahdavi M; Khaledi A; Esmaeili SA; Esmaeili D; Sahebkar A
Microb Pathog; 2018 Aug; 121():100-105. PubMed ID: 29709690
[TBL] [Abstract][Full Text] [Related]
42. Intranasal immunization with an epitope-based vaccine results in earlier protection, but not better protective efficacy, against Helicobacter pylori compared to subcutaneous immunization.
Li H; Zhang J; He Y; Li B; Chen L; Huang W; Zou Q; Wu C
Immunol Res; 2015 Jul; 62(3):368-76. PubMed ID: 26044541
[TBL] [Abstract][Full Text] [Related]
43. [Immunopotency of the recombinant urease B subunit vaccine of Helicobacter pylori after intranasal administration to mice].
Gao ZG; Zou QM; Guo G; Guo TS; Zou QM; Zeng WK; Xie QH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):68-70. PubMed ID: 15132912
[TBL] [Abstract][Full Text] [Related]
44. Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model.
Liu KY; Shi Y; Luo P; Yu S; Chen L; Zhao Z; Mao XH; Guo G; Wu C; Zou QM
Vaccine; 2011 Sep; 29(38):6679-85. PubMed ID: 21745524
[TBL] [Abstract][Full Text] [Related]
45. Intranasal immunization with immunodominant epitope peptides derived from HpaA conjugated with CpG adjuvant protected mice against Helicobacter pylori infection.
Yang WC; Sun HW; Sun HQ; Yuan HM; Li B; Li HB; Hu J; Yang Y; Zou QM; Guo H; Wu C; Chen L
Vaccine; 2018 Oct; 36(42):6301-6306. PubMed ID: 30217524
[TBL] [Abstract][Full Text] [Related]
46. Development and evaluation of a DNA vaccine based on Helicobacter pylori urease B: failure to prevent experimental infection in the mouse model.
Zavala-Spinetti L; Breslin MB; Correa H; Bégué RE
Helicobacter; 2006 Dec; 11(6):517-22. PubMed ID: 17083372
[TBL] [Abstract][Full Text] [Related]
47. Oral immunization of BALB/c mice with recombinant Helicobacter pylori antigens and double mutant heat-labile toxin (dmLT) induces prophylactic protective immunity against H. pylori infection.
Zhong Y; Chen J; Liu Y; Zhang Y; Tang C; Wang X; Wang P; Chen W; Wei B; Liu M
Microb Pathog; 2020 Aug; 145():104229. PubMed ID: 32353579
[TBL] [Abstract][Full Text] [Related]
48. The role of outer inflammatory protein A (OipA) in vaccination of theC57BL/6 mouse model infected by Helicobacter pylori.
Mahboubi M; Falsafi T; Sadeghizadeh M; Mahjoub F
Turk J Med Sci; 2017 Feb; 47(1):326-333. PubMed ID: 28263510
[TBL] [Abstract][Full Text] [Related]
49. Therapeutic Protection Against
Guo L; Hong D; Wang S; Zhang F; Tang F; Wu T; Chu Y; Liu H; He M; Yang H; Yin R; Liu K
Front Immunol; 2019; 10():1185. PubMed ID: 31191547
[TBL] [Abstract][Full Text] [Related]
50. Nongenetically modified Lactococcus lactis-adjuvanted vaccination enhanced innate immunity against Helicobacter pylori.
Liu W; Tan Z; Liu H; Zeng Z; Luo S; Yang H; Zheng L; Xi T; Xing Y
Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28805287
[TBL] [Abstract][Full Text] [Related]
51. Oral immunization with recombinant Mycobacterium smegmatis expressing the outer membrane protein 26-kilodalton antigen confers prophylactic protection against Helicobacter pylori infection.
Lü L; Zeng HQ; Wang PL; Shen W; Xiang TX; Mei ZC
Clin Vaccine Immunol; 2011 Nov; 18(11):1957-61. PubMed ID: 21900527
[TBL] [Abstract][Full Text] [Related]
52. Advances in vaccination against Helicobacter pylori.
Velin D; Michetti P
Expert Rev Gastroenterol Hepatol; 2010 Apr; 4(2):157-66. PubMed ID: 20350263
[TBL] [Abstract][Full Text] [Related]
53. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
[TBL] [Abstract][Full Text] [Related]
54. Protective efficacy of recombinant urease B and aluminum hydroxide against Helicobacter pylori infection in a mouse model.
Bégué RE; Sadowska-Krowicka H
FEMS Immunol Med Microbiol; 2010 Nov; 60(2):142-6. PubMed ID: 20731722
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of superoxide dismutase from Helicobacter pylori as a protective vaccine antigen.
Every AL; Stent A; Moloney MB; Ng GZ; Skene CD; Edwards SJ; Sutton P
Vaccine; 2011 Feb; 29(7):1514-8. PubMed ID: 21172379
[TBL] [Abstract][Full Text] [Related]
56. Mucosal vaccination increases local chemokine production attracting immune cells to the stomach mucosa of Helicobacter pylori infected mice.
Flach CF; Mozer M; Sundquist M; Holmgren J; Raghavan S
Vaccine; 2012 Feb; 30(9):1636-43. PubMed ID: 22230589
[TBL] [Abstract][Full Text] [Related]
57. Th immune response induced by H pylori vaccine with chitosan as adjuvant and its relation to immune protection.
Xie Y; Zhou NJ; Gong YF; Zhou XJ; Chen J; Hu SJ; Lu NH; Hou XH
World J Gastroenterol; 2007 Mar; 13(10):1547-53. PubMed ID: 17461447
[TBL] [Abstract][Full Text] [Related]
58. Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: safety, immunogenicity, and efficacy.
Rossi G; Ruggiero P; Peppoloni S; Pancotto L; Fortuna D; Lauretti L; Volpini G; Mancianti S; Corazza M; Taccini E; Di Pisa F; Rappuoli R; Del Giudice G
Infect Immun; 2004 Jun; 72(6):3252-9. PubMed ID: 15155627
[TBL] [Abstract][Full Text] [Related]
59. Oral vaccination with liposome-encapsulated recombinant fusion peptide of urease B epitope and cholera toxin B subunit affords prophylactic and therapeutic effects against H. pylori infection in BALB/c mice.
Zhao W; Wu W; Xu X
Vaccine; 2007 Nov; 25(44):7664-73. PubMed ID: 17913305
[TBL] [Abstract][Full Text] [Related]
60. Effects of oral vaccination and immunomodulation by cholera toxin on experimental Helicobacter pylori infection, reinfection, and gastritis.
Raghavan S; Svennerholm AM; Holmgren J
Infect Immun; 2002 Aug; 70(8):4621-7. PubMed ID: 12117975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
